Formulation and Evaluation of A Novel in Situ Gel of Moxifloxacin Drug

The present work describes the formulation and evaluation activated of an ophthalmic delivery system of ananti-bacterial agent- Moxifloxacin. Sodium alginate was used as the gelling agent for Ion activated in situgel, Polyacrylic acid (Carbopol- 934) was used as the gelling agent for pH-triggered in situ gel andPoloxamer was used as the gelling agent for temperature activated in situ gel in combination with HPMC K4M which acted as a viscosity enhancing agent. The evaluated for determination of visual appearance, clarity,pH and Drug Content, In vitro gelation studies, Rheological studies, In vitro drug release study, antimicrobialefficacy Studies, Ocular irritation studies, Sterility testing, Stability studies. Cumulative percent release of86.89 %, 63.23 % and 76.37 %, was observed for optimized formulations

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-07
DOI
https://doi.org/10.5281/zenodo.15615575
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Formulation and Evaluation of A Novel in Situ Gel of Moxifloxacin Drug

Zenodo (CERN European Organization for Nuclear Research)
Advanced Drug Delivery Systems
article

Formulation and Evaluation of A Novel in Situ Gel of Moxifloxacin Drug

article en

Abstract

The present work describes the formulation and evaluation activated of an ophthalmic delivery system of ananti-bacterial agent- Moxifloxacin. Sodium alginate was used as the gelling agent for Ion activated in situgel, Polyacrylic acid (Carbopol- 934) was used as the gelling agent for pH-triggered in situ gel andPoloxamer was used as the gelling agent for temperature activated in situ gel in combination with HPMC K4M which acted as a viscosity enhancing agent. The evaluated for determination of visual appearance, clarity,pH and Drug Content, In vitro gelation studies, Rheological studies, In vitro drug release study, antimicrobialefficacy Studies, Ocular irritation studies, Sterility testing, Stability studies. Cumulative percent release of86.89 %, 63.23 % and 76.37 %, was observed for optimized formulations

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 64%
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.